Show simple item record

dc.contributor.advisorHutt, Peter Bartonen_US
dc.contributor.authorZollinger, Gerien_US
dc.date.accessioned2012-06-07T20:16:02Z
dc.date.issued2003en_US
dc.identifier.citationReassessing Pre-market Regulation of Class III Medical Devices (2003 Third Year Paper)en
dc.identifier.urihttp://nrs.harvard.edu/urn-3:HUL.InstRepos:8852137
dc.description.abstractRegulation of medical devices has evolved over the past twenty-five years. Initially, Congress created a regime where the safety and efficacy of all medical devices would be reviewed to varying degrees, depending on the risk posed by the device. Class III devices, the most dangerous class of devices, were to each have a safety and efficacy review. To permit new market entrants on similar grounds as those marketing devices prior to the 1976 Amendments, Congress also created a premarket notification program, under which new devices were regulated in the same way as the pre-Amendment counterparts. However, the premarket notification program has evolved and taken over market authorization for all devices, including Class III devices. This paper argues that the premarket notification program has changed so much that it should be entirely eliminated for Class III medical devices.en
dc.language.isoen_USen
dash.licenseLAAen_US
dc.subjectFood and Drug Lawen
dc.subjectmedical devicesen
dc.subjectpre-marketen
dc.subjectregulationen
dc.titleReassessing Pre-market Regulation of Class III Medical Devicesen
dc.typePaper (for course/seminar/workshop)en_US
dc.date.available2012-06-07T20:16:02Z
dash.authorsorderedfalse


Files in this item

Thumbnail
Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record